Literature DB >> 8639865

Transplantation of allogeneic CD34+ blood cells.

H Link1, L Arseniev, O Bähre, J G Kadar, H Diedrich, H Poliwoda.   

Abstract

Pluripotent stem cells of hematopoiesis and lymphopoiesis are among the CD34+ cells in blood or bone marrow. After granulocyte-colony stimulating factor (G-CSF) treatment, 1% to 2% of the mononuclear cells in blood are CD34+ cells, which can be procured by leukapheresis. We investigated the potential of CD34+ blood cells for reconstituting hematopoiesis and lymphopoiesis after allogeneic transplantation. HLA-identical sibling donors of 10 patients with hematologic malignancies were treated with G-CSF (filgrastim), 5 microgram/kg subcutaneously twice daily for 5 to 7 days. CD34+ cells were selected from the apheresis concentrates by immunoadsorption, concomitantly the number of T cells was reduced 100- to 1,000-fold. After transplantation, five patients received cyclosporine A for graft-versus-host disease (GvHD) prophylaxis (group I); five patients additionally received methotrexate (group II). G-CSF and erythropoietin were given to all patients. Mean numbers of 7.45 x 10(6) CD34+ and 1.2 x 10(6) CD3+ cells per kilogram were transplanted. In group I, the median times of neutrophil recovery to 100, 500, and 1,000 per mm3 were 10, 10, and 11 days, respectively. Group II patients reached these neutrophil levels after 10, 14, and 15 days, respectively. Platelet transfusions were administered for a median of 18 days in group I and 30 days in group II, and red blood cells for 9 and 12 days, respectively. Between day 30 and 60, lymphocytes reached levels of 353 +/- 269 cells per mm3. The median grades of acute GvHD were III in group I and I in group II. Two patients in group I died from acute GvHD. Two leukemic relapses occurred in group II. Complete and stable donor hematopoiesis was shown in all patients with a median follow up of 370 (45 to 481) days. Allogeneic blood CD34+ cells can successfully reconstitute hematopoiesis and lymphopoiesis. Reduction of T cells by CD34+ blood cell enrichment and cyclosporine A alone might not be sufficient for prophylaxis of severe acute GvHD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639865

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Specific protein markers for stem cell cross-talk with neighboring cells in the environment.

Authors:  Kyung Soo Park; Seung Won Shin; Jeong-Woo Choi; Soong Ho Um
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

Review 2.  Supportive care in patients with acute leukaemia: historical perspectives.

Authors:  Giovanna Cannas; Xavier Thomas
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

3.  Distinctive Leukocyte Subpopulations According to Organ Type in Cynomolgus Macaques.

Authors:  Jonah S Zitsman; Paula Alonso-Guallart; Christopher Ovanez; Yojiro Kato; Joanna F Rosen; Joshua I Weiner; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

4.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

Authors:  M Bhatia; J C Wang; U Kapp; D Bonnet; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Differential regulation of the human and murine CD34 genes in hematopoietic stem cells.

Authors:  Yutaka Okuno; Hiromi Iwasaki; Claudia S Huettner; Hanna S Radomska; David A Gonzalez; Daniel G Tenen; Koichi Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

6.  Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.

Authors:  Tâm D Quách; Thomas J Hopkins; Nichol E Holodick; Raja Vuyyuru; Tim Manser; Ruthee-Lu Bayer; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

7.  Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice.

Authors:  Christopher J Hogan; Elizabeth J Shpall; Gordon Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

8.  RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element.

Authors:  Elena Levantini; Sanghoon Lee; Hanna S Radomska; Christopher J Hetherington; Meritxell Alberich-Jorda; Giovanni Amabile; Pu Zhang; David A Gonzalez; Junyan Zhang; Daniela S Basseres; Nicola K Wilson; Steffen Koschmieder; Gang Huang; Dong-Er Zhang; Alexander K Ebralidze; Constanze Bonifer; Yutaka Okuno; Bertie Gottgens; Daniel G Tenen
Journal:  EMBO J       Date:  2011-08-26       Impact factor: 11.598

9.  Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF).

Authors:  Hartmut Link
Journal:  Support Care Cancer       Date:  2022-09       Impact factor: 3.359

10.  IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells.

Authors:  Zeynab Aliyari; Sara Soleimanirad; Manizheh Sayyah Melli; Hamid Tayefi Nasrabadi; Hojjatollah Nozad Charoudeh
Journal:  Adv Pharm Bull       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.